Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ABOBOTULINUMTOXINA vs ABROCITINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ABOBOTULINUMTOXINA vs ABROCITINIB: Safety Overview

Metric ABOBOTULINUMTOXINA ABROCITINIB
Total FAERS Reports 5,789 3,170
Deaths Reported 109 57
Death Rate 1.9% 1.8%
Hospitalizations 406 329
Average Patient Age 46.6 yrs 48.5 yrs
% Female Patients 87.3% 53.9%
FDA Approval Date N/A Jan 14, 2022
Manufacturer N/A U.S. Pharmaceuticals
Route N/A ORAL
Marketing Status Prescription Prescription